|
[1]SU XQ, YAO DF, XU AB, et al.HCC patients immunity after treatment with Thlidomide combined with transcatheter arterial chemoembolization[J].J Med Res, 2012, 41 (5) :135-137. (in Chinese) 苏小琴, 姚登福, 徐爱兵, 等.肽胺哌啶酮联合TACE治疗原发性肝癌后免疫功能的变化[J].医学研究杂志, 2012, 41 (5) :135-137.
|
|
[2]LLOVET JM, REAL MI, MONTAFIA X, et al.Barcelona Liver Cancer Group Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:a randomised controlled trial[J].Lancet, 2002, 359 (9319) :1734-1739.
|
|
[3]LO CM, NGAN H, TSO WK, et al.Rnadomized controlled trial of transarterial lipiodol chemoembolization for unreseetable hepatocellular carcinoma[J].Hepatology, 2002, 35 (5) :1164-1171.
|
|
[4]LLOVET JM, BRNIX J.Unresectable hepatocellular carcinoma:meta analysis of arterial embolization[J].Radiology, 2004, 230 (1) :300-301.
|
|
[5]YANG W, HU NQ, Mo RX.Prognostic factors of TACE primary hepatic carcinoma[J].Chin J Postgradutes Med, 2010, 33 (32) :52-54. (in Chinese) 杨威, 胡虞乾, 莫瑞祥.原发性肝癌肝动脉栓塞化疗术后生存分析[J].中国医师进修杂志, 2010, 33 (32) :52-54.
|
|
[6]AHMAD J, RHEE J, CARR BI.The effects of hepatic artery chemotherapy on viral hepatitis in patients with hepatocellular carcinoma[J].Dig Dis Sci, 2005, 50 (2) :331-335.
|
|
[7]PENG JW, LIN GN, XIAO JJ, et al.Hepatitis B virus reactivation in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization therapy[J].Asia Pac J Clin Oncol, 2012, 8 (4) :356-361.
|
|
[8]JANG JW, CHOI JY, BAE SH.A randomized controlled study of preem-ptive lamivudinein patients receiving transarterial chemo-lipiodolization[J].Hepalology, 2006, 43 (6) :233-240.
|
|
[9]KEEFFE EB, DIETERICH DT, HAN SH.A treatment algorithm for the management of chronic hepatitis B virus infection in the United States:an updat[J].Clin Gastruenterol Hepatol, 2006, 4 (8) :936-962.
|
|
[10]NAGAMATSU H, ITANO S, NAGAOKA S.Prophylactic lamivudine administration prevents exacerbation of liver damage in HBe antigen positive patients with hepatocellular carcinoma undergoing transhepatic arterial infusion chemothera[J].Am J Gastroenterol, 2004, 99 (12) :2369-2375.
|
|
[11]GUO HH, CHAO Y, LI Y, et al.Antiviral treatment influence on life quality of patients with HBV-related primary liver cancer[J].Chin Hepatol, 2012, 17 (2) :83-86. (in Chinese) 郭宏华, 晁阳, 李岩, 等.抗病毒治疗对乙型肝炎相关原发性肝癌患者生活质量及预后的影响[J].肝脏, 2012, 17 (2) :83-86.
|
|
[12]WU HY, YOU DH.Lamivudine combined with transcatheter arterial chemoembolization on treatment of advanced hepatocellular carcinoma with cirrhosis[J].Modern J Integr Tradit Chin West Med, 2011, 20 (15) :1833-1834. (in Chinese) 吴杭源, 尤德宏.拉米夫定联合TACE治疗合并肝硬化的中晚期原发性肝癌[J].现代中西医结合杂志, 2011, 20 (15) :1833-1834.
|
|
[13]ZHAN GQ, TAN HB, ZHU L, et al.Antiviral effects of transcatheter hepatic arterial chemoembolization on m iddle and advanced stage hepatitis B virus-related liver cancer[J].J Clin Hepatol, 2010, 26 (4) :423-431. (in Chinese) 占国清, 谭华炳, 朱琳, 等.抗病毒对肝动脉化疗栓塞治疗乙型肝炎后中晚期肝癌的作用[J].临床肝胆病杂志, 2010, 26 (4) :423-431.
|
|
[14]GUO XP, LIU YW, WAN W, et al.Treatment of liver cirrhosis with postoperative hepatocellular carcinoma with nucleoside analog[J].J Clin Hepatol, 2010, 26 (4) :425-427. (in Chinese) 郭西萍, 刘彦威, 王婉, 等.核苷类抗病毒治疗伴活动性肝硬化肝癌术后的临床观察[J].临床肝胆病杂志, 2010, 26 (4) :425-427.
|
DownLoad: